PathMaker Neurosystems Inc., a clinical-stage neurotechnology company developing non-invasive neurotherapy systems for the treatment of patients with neuromotor disorders, recently announced that it has launched an Institutional Review Board (IRB)-approved human clinical trial in conjunction with Northwell Health (formerly North Shore-LIJ Health System) and The Feinstein Institute for Medical Research to evaluate the safety and
The post PathMaker Neurosystems and Feinstein Institute announce initiation of first clinical trial of MyoRegulator to treat muscle contraction appeared first on Medical Design and Outsourcing.